Literature DB >> 4359399

Renal hypertension in rats immunized against angiotensin I and angiotensin II.

H F Oates, G S Stokes, B G Storey, R G Glover, B F Snow.   

Abstract

Rats, actively immunized against angiotensin I (AI) and angiotensin II (AII), were subjected to unilateral renal artery constriction to determine whether the resulting hypertension, which may still ensue in the animal immunized against AII, could be prevented by such combined immunity. Sustained immunity to both AI and AII neither changed preoperative blood pressures of the rats from those of control mock-immunized rats nor altered the incidence or severity of renal dip hypertension. Vascular hyperresponsiveness to small quantities of free angiotensin could not be invoked to explain the hypertension, for there was no significant difference between mock-immunized hypertensive animals, and those remaining normotensive, regarding pressor sensitivity to intravenous AI, AII, renin, and norepinephrine. (AI + AII)-immunized hypertensive rats required AI doses averaging 260 times greater than nonimmune hypertensives to elicit equipressor responses, and were refractory to renin, but not to norepinephrine. Thus, while previous studies have not excluded direct participation of endogenous AI in renal clip hypertension in rats, evidence from our experiments makes it extremely difficult to sustain any pressor function therein for circulating AI or AII. Our results also preclude involvement of AII produced from circulating AI by conversion within arteriolar walls, close to receptor sites, since AI immunity would block this mechanism of action.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4359399      PMCID: PMC2139522          DOI: 10.1084/jem.139.2.239

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  16 in total

1.  Increased vascular reactivity in experimental hypertension.

Authors:  D B GORDON; A NOGUEIRA
Journal:  Circ Res       Date:  1962-03       Impact factor: 17.367

2.  Vascular reactivity in hypertension.

Authors:  A E DOYLE; J R FRASER
Journal:  Circ Res       Date:  1961-05       Impact factor: 17.367

3.  Reactivity to pressor agents in hypertension.

Authors:  A E DOYLE; H BLACK
Journal:  Circulation       Date:  1955-12       Impact factor: 29.690

Review 4.  The renin-angiotensin system and hypertension.

Authors:  F Gross
Journal:  Ann Intern Med       Date:  1971-11       Impact factor: 25.391

5.  Renovascular hypertension in rats immunized with angiotensin II.

Authors:  I Eide
Journal:  Circ Res       Date:  1972-02       Impact factor: 17.367

6.  Renal-clip hypertension in rabbits immunized against angiotensin II.

Authors:  G J Macdonald; W J Louis; V Renzini; G W Boyd; W S Peart
Journal:  Circ Res       Date:  1970-08       Impact factor: 17.367

7.  Plasma renin activity in hypertensive rats after treatment with renin preinhibitor.

Authors:  S Sen; R R Smeby; F M Bumpus
Journal:  Am J Physiol       Date:  1969-03

8.  Vascular responses in mesenteric arteries from genetic and renal hypertensive rats.

Authors:  D D McGregor; F H Smirk
Journal:  Am J Physiol       Date:  1968-06

9.  Role of the renin-angiotensin system in the pathogenesis of severe hypertension in rats.

Authors:  O A Carretero; P Kuk; S Piwonska; J A Houle; M Marin-Grez
Journal:  Circ Res       Date:  1971-12       Impact factor: 17.367

10.  Effect of rabbit antibodies against angiotensin-II on the pressor response to angiotensin-II and renal hypertension in the rat.

Authors:  P R Hedwall
Journal:  Br J Pharmacol       Date:  1968-11       Impact factor: 8.739

View more
  2 in total

1.  Active immunization with angiotensin I peptide analogue vaccines selectively reduces the pressor effects of exogenous angiotensin I in conscious rats.

Authors:  S M Gardiner; T R Auton; M R Downham; H L Sharp; P A Kemp; J E March; H Martin; P J Morgan; A Rushton; T Bennett; J F Glover
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

2.  Role of extrapulmonary conversion in mediating the systemic pressor activity of angiotensin I.

Authors:  H F Oates; G S Stokes
Journal:  J Exp Med       Date:  1974-07-01       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.